Search
for
Sort by
Research 301–330 of 1000+
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Systematic Analysis of Non-coding RNAs Involved in the Angora Rabbit (Oryctolagus cuniculus) Hair Follicle Cycle by RNA Sequencing
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis
- Hair cycle control by leptin as a new anagen inducer
- A bald statement - Current approaches to manipulate miniaturisation focus only on promoting hair growth
- Advances in Understanding Hair Growth
- The effects of centipedegrass extract on hair growth via promotion of anagen inductive activity
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- TGFβ family mimetic peptide promotes proliferation of human hair follicle dermal papilla cells and hair growth in C57BL/6 mice
- JAK inhibitors in dermatology: The promise of a new drug class
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- JAK Inhibitors for Treatment of Alopecia Areata
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review